Suchergebnisse - "Qin, Shukui"

PubPharm (4)

1

Quantification of Treatment Effect of Tislelizumab vs Sorafenib for Hepatocellular Carcinoma-Reply

enthalten in: JAMA oncology | 2024

von Qin, S.

2

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2023

von Qin, S. | Kudo, M. | Meyer, T. | +13

3

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer : The REALITY Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Lin, Y. | Qin, S. | Li, Z. | +22

CommentIn: JAMA Oncol. 2022 Feb 1;8(2):250-251. - PMID 34913944

4

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer : Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial

enthalten in: JAMA oncology | 2017

von Chu, M. | Hecht, J. | Slamon, D. | +17

CommentIn: JAMA Oncol. 2018 Feb 1;4(2):264. - PMID 29098270

1
[1]